A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal Cancer

NCT03356158 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

BIOLOGICAL: CPGJ602
BIOLOGICAL: Cetuximab

Sponsor

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.